Fundamental analysis · SEC EDGAR · TTM through 31/03/2026
BTSG · Nasdaq · Healthcare
Fundamental quality
59
out of 100
Source: SEC EDGAR · TTM through 31/03/2026
The score combines growth, profitability and financial strength. Here its growth weighs in its favor, while its profitability drags it down the most.
| Year | Revenue | Net income | Free cash flow | Net debt |
|---|---|---|---|---|
| 2022 | 7,721 | -54 | -75 | — |
| 2023 | 7,691 | -155 | 137 | 3,351 |
| 2024 | 10,072 | -18 | -57 | 2,550 |
| 2025 | 12,911 | 191 | 395 | 2,419 |
Between 2022 and 2025, revenue went from $7,721M to $12,911M (+67%) and net income went from -$54M to $191M (+454%).
Annual figures in millions of U.S. dollars ($M) per SEC filings. Net debt is total debt minus cash.
Is Brightspring Health Services, Inc. a profitable company?
Brightspring Health Services, Inc. is profitable, with a net margin of 2.3%, though a thin one.
Does Brightspring Health Services, Inc. have a lot of debt?
Yes, its leverage is high: net debt is 3.05 times its EBITDA.
Is Brightspring Health Services, Inc. growing?
Its revenue has grown 19.2% annualized in recent years.
Does Brightspring Health Services, Inc. generate cash?
Yes. It converts about 3% of its revenue into free cash flow.
The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.
Is Brightspring Health Services, Inc. cheap or expensive?
That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).
Compute the valuation →Brokers you can use to invest in U.S. and European stocks.
The serious investor's standard →
Popular in the U.S. →
Other analyses
NVIDIA (NVDA) · Microsoft (MSFT) · Apple (AAPL) · Alphabet (Google) (GOOGL) · Amazon (AMZN) · Meta Platforms (META) · see more →